Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...

Re-Assaying up to 36,614m of historic drilling to accelerate development and save Temas approximately $40 million in future drilling costsHighlightsPreliminary indications from historical data review ...

Findings could streamline enrollment for Alzheimer's clinical trials ...

DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...

The driving force behind the lab was a desire to control biomarker discovery, streamline regulatory approvals for CDx, and develop drugs more cheaply and quickly.

Merlin CP-GEP is the only molecular test recognized by NCCN as predictive and appropriate for use in select T1 and T2 patients to support shared decision-making regarding Sentinel Lymph Node ...

Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators under a new federal initiative designed to ...

Full-year revenue increased 10% to $727 million;Full-year clinical revenue grew 15%, or 13% excluding the Pathline acquisition;Successfully resolved RaDaR ST patent litigationFORT MYERS, ...

QINGDAO, SHANDONG, CHINA, February 6, 2026 /EINPresswire.com/ -- Mentioning precious metal detection, the fire assay ...

QINGDAO, SHANDONG, CHINA, February 6, 2026 /EINPresswire.com/ -- Do you know about mobile container labs? Centered on ...

Integration of the Xenometrix Ames mutagenicity test modernizes this cornerstone, regulatory-aligned NAM within the ...